Oak Associates’s Celgene Corp CELG Stock Holding History

Oak Associates’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-36,480	Closed	-$3.62M	–	155
2019 Q3	$3.62M	Sell	36,480 -2,339	-6%	-$222K	0.22%	69
2019 Q2	$3.59M	Sell	38,819 -19,475	-33%	-$1.85M	0.22%	69
2019 Q1	$5.5M	Sell	58,294 -51	-0.1%	-$4.46K	0.34%	65
2018 Q4	$3.74M	Buy	58,345 +32,745	+128%	+$2.42M	0.26%	70
2018 Q3	$2.29M	Buy	25,600 +6,900	+37%	+$610K	0.14%	87
2018 Q2	$1.49M	Hold	18,700	–	–	0.1%	95
2018 Q1	$1.67M	Hold	18,700	–	–	0.12%	92
2017 Q4	$1.95M	Buy	+18,700	New	+$2.11M	0.14%	87

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Oak Associates's CELG Position: Q4 2019 in Review

Oak Associates sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 36,480 shares — an estimated $3.62M sold.

Oak Associates first reported a position in CELG in Q4 2017 and held it in 8 quarters. The position peaked at $5.5M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Oak Associates reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Oak Associates sold 36,480 Celgene Corp shares in Q4 2019, an estimated $3.62M.
Oak Associates first reported a position in Celgene Corp in Q4 2017 and held it in 8 quarters.
Oak Associates's Celgene Corp position peaked at $5.5M in Q1 2019.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Oak Associates's 13F filing for Q4 2019, filed 13 Feb 2020.